$1.43B Market Cap.
PRAX Market Cap. (MRY)
PRAX Shares Outstanding (MRY)
PRAX Assets (MRY)
Total Assets
$483.11M
Total Liabilities
$37.66M
Total Investments
$254.16M
PRAX Income (MRY)
Revenue
$8.55M
Net Income
-$182.82M
Operating Expense
$208.72M
PRAX Cash Flow (MRY)
CF Operations
-$131.76M
CF Investing
-$248.49M
CF Financing
$514.32M
PRAX Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
PRAX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $483,110,000 (449.31%) | $87,948,000 (-23.61%) | $115,128,000 (-60.67%) | $292,747,000 (-3.44%) |
Assets Current | $404,372,000 (376.40%) | $84,880,000 (-23.42%) | $110,840,000 (-61.43%) | $287,409,000 (-4.93%) |
Assets Non-Current | $78,738,000 (2466.43%) | $3,068,000 (-28.45%) | $4,288,000 (-19.67%) | $5,338,000 (527.26%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $445,450,000 (539.38%) | $69,669,000 (-8.46%) | $76,106,000 (-69.66%) | $250,812,000 (-12.75%) |
Property Plant & Equipment Net | $1,361,000 (-48.68%) | $2,652,000 (-31.51%) | $3,872,000 (-20.43%) | $4,866,000 (482.06%) |
Cash & Equivalents | $215,372,000 (164.91%) | $81,300,000 (31.95%) | $61,615,000 (-55.58%) | $138,704,000 (-53.24%) |
Accumulated Other Comprehensive Income | $654,000 (0%) | $0 (0%) | -$173,000 (1.70%) | -$176,000 (0%) |
Deferred Revenue | $0 (0%) | $2,553,000 (-48.94%) | $5,000,000 (0%) | $0 (0%) |
Total Investments | $254,156,000 (0%) | $0 (0%) | $38,874,000 (-71.67%) | $137,207,000 (0%) |
Investments Current | $177,195,000 (0%) | $0 (0%) | $38,874,000 (-71.67%) | $137,207,000 (0%) |
Investments Non-Current | $76,961,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $12,528,000 (115.44%) | $5,815,000 (-60.37%) | $14,672,000 (36.10%) | $10,780,000 (163.70%) |
Accumulated Retained Earnings (Deficit) | -$836,740,000 (-27.96%) | -$653,921,000 (-23.23%) | -$530,644,000 (-67.60%) | -$316,615,000 (-111.71%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,369,000 (-45.13%) | $2,495,000 (-28.71%) | $3,500,000 (-18.81%) | $4,311,000 (465.01%) |
Debt Current | $1,259,000 (11.81%) | $1,126,000 (12.04%) | $1,005,000 (24.07%) | $810,000 (6.16%) |
Debt Non-Current | $110,000 (-91.96%) | $1,369,000 (-45.13%) | $2,495,000 (-28.73%) | $3,501,000 (0%) |
Total Liabilities | $37,660,000 (106.03%) | $18,279,000 (-53.16%) | $39,022,000 (-6.95%) | $41,935,000 (166.76%) |
Liabilities Current | $37,550,000 (138.43%) | $15,749,000 (-54.14%) | $34,345,000 (-10.64%) | $38,434,000 (144.49%) |
Liabilities Non-Current | $110,000 (-95.65%) | $2,530,000 (-45.91%) | $4,677,000 (33.59%) | $3,501,000 (0%) |
PRAX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $8,553,000 (249.53%) | $2,447,000 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $56,305,000 (33.89%) | $42,054,000 (-29.85%) | $59,946,000 (27.34%) | $47,075,000 (177.04%) |
Research & Development Expense | $152,413,000 (75.66%) | $86,766,000 (-44.04%) | $155,040,000 (28.92%) | $120,257,000 (167.38%) |
Operating Expenses | $208,718,000 (62.02%) | $128,820,000 (-40.08%) | $214,986,000 (28.48%) | $167,332,000 (170.03%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$182,819,000 (-48.30%) | -$123,277,000 (42.40%) | -$214,029,000 (-28.11%) | -$167,061,000 (-170.24%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$182,819,000 (-48.30%) | -$123,277,000 (42.40%) | -$214,029,000 (-28.11%) | -$167,061,000 (-170.24%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$182,819,000 (-48.30%) | -$123,277,000 (42.40%) | -$214,029,000 (-28.11%) | -$167,061,000 (-137.56%) |
Weighted Average Shares | $17,906,794 (171.55%) | $6,594,316 (114.58%) | $3,073,116 (-92.76%) | $42,454,055 (374.34%) |
Weighted Average Shares Diluted | $17,906,794 (171.55%) | $6,594,316 (114.58%) | $3,073,116 (-92.76%) | $42,454,055 (374.34%) |
Earning Before Interest & Taxes (EBIT) | -$182,819,000 (-48.30%) | -$123,277,000 (42.40%) | -$214,029,000 (-28.11%) | -$167,061,000 (-170.20%) |
Gross Profit | $8,553,000 (249.53%) | $2,447,000 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$200,165,000 (-58.39%) | -$126,373,000 (41.22%) | -$214,986,000 (-28.48%) | -$167,332,000 (-170.03%) |
PRAX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$248,494,000 (-737.98%) | $38,950,000 (-59.80%) | $96,889,000 (168.95%) | -$140,520,000 (0%) |
Net Cash Flow from Financing | $514,323,000 (459.83%) | $91,871,000 (777.89%) | $10,465,000 (-90.27%) | $107,586,000 (-64.66%) |
Net Cash Flow from Operations | -$131,757,000 (-18.55%) | -$111,136,000 (39.94%) | -$185,043,000 (-48.56%) | -$124,554,000 (-136.69%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $134,072,000 (581.09%) | $19,685,000 (125.34%) | -$77,689,000 (50.67%) | -$157,488,000 (-162.55%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$248,494,000 (-737.16%) | $39,000,000 (-59.93%) | $97,333,000 (169.79%) | -$139,470,000 (0%) |
Capital Expenditure | $0 (0%) | -$50,000 (88.74%) | -$444,000 (57.71%) | -$1,050,000 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $514,631,000 (461.87%) | $91,592,000 (754.00%) | $10,725,000 (-90.03%) | $107,586,000 (-46.47%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $41,360,000 (66.39%) | $24,857,000 (-13.07%) | $28,593,000 (26.00%) | $22,693,000 (335.48%) |
Depreciation Amortization & Accretion | $1,291,000 (1.73%) | $1,269,000 (8.37%) | $1,171,000 (-26.54%) | $1,594,000 (113.67%) |
PRAX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% | - | - |
Profit Margin | -2137.50% (57.57%) | -5037.90% | - | - |
EBITDA Margin | -2122.40% (57.43%) | -4986.00% | - | - |
Return on Average Equity (ROAE) | -49.50% (67.22%) | -151.00% (9.85%) | -167.50% (-187.31%) | -58.30% (14.39%) |
Return on Average Assets (ROAA) | -46.00% (60.21%) | -115.60% (9.26%) | -127.40% (-138.13%) | -53.50% (-33.42%) |
Return on Sales (ROS) | -2137.50% (57.57%) | -5037.90% | - | - |
Return on Invested Capital (ROIC) | -90.60% (-106.68%) | 1357.10% (547.59%) | -303.20% (-153.94%) | -119.40% (-110.49%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -7.54 (-532.38%) | -1.19 (-132.36%) | -0.51 (89.74%) | -5 (28.57%) |
Price to Sales Ratio (P/S) | 161.13 (168.36%) | 60.04 | - | - |
Price to Book Ratio (P/B) | 3.22 (17.48%) | 2.74 (85.96%) | 1.47 (-58.16%) | 3.52 (-51.89%) |
Debt to Equity Ratio (D/E) | 0.09 (-67.56%) | 0.26 (-48.93%) | 0.51 (207.19%) | 0.17 (203.64%) |
Earnings Per Share (EPS) | -10.21 (45.37%) | -18.69 (73.15%) | -69.6 (-1666.50%) | -3.94 (49.87%) |
Sales Per Share (SPS) | 0.48 (28.84%) | 0.37 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -7.36 (56.36%) | -16.86 (72.07%) | -60.36 (-1939.81%) | -2.96 (49.68%) |
Book Value Per Share (BVPS) | 24.88 (135.46%) | 10.56 (-57.34%) | 24.77 (319.18%) | 5.91 (-81.61%) |
Tangible Assets Book Value Per Share (TABVPS) | 26.98 (102.29%) | 13.34 (-64.40%) | 37.46 (443.26%) | 6.9 (-79.64%) |
Enterprise Value Over EBIT (EV/EBIT) | -7 (-600.00%) | -1 (0%) | 0 (0%) | -4 (87.50%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -6.98 (-819.89%) | -0.76 (-202.39%) | -0.25 (94.25%) | -4.37 (86.60%) |
Asset Turnover | 0.02 (-4.35%) | 0.02 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 10.77 (99.80%) | 5.39 (67.03%) | 3.23 (-56.85%) | 7.48 (-61.12%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$131,757,000 (-18.50%) | -$111,186,000 (40.06%) | -$185,487,000 (-47.68%) | -$125,604,000 (-138.69%) |
Enterprise Value (EV) | $1,267,378,318 (1268.50%) | $92,610,826 (73.31%) | $53,435,216 (-92.60%) | $722,392,807 (-63.71%) |
Earnings Before Tax (EBT) | -$182,819,000 (-48.30%) | -$123,277,000 (42.40%) | -$214,029,000 (-28.11%) | -$167,061,000 (-170.20%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$181,528,000 (-48.78%) | -$122,008,000 (42.68%) | -$212,858,000 (-28.64%) | -$165,467,000 (-170.89%) |
Invested Capital | $231,557,000 (3605.25%) | -$6,606,000 (-129.14%) | $22,668,000 (-81.10%) | $119,920,000 (1529.66%) |
Working Capital | $366,822,000 (430.62%) | $69,131,000 (-9.63%) | $76,495,000 (-69.28%) | $248,975,000 (-13.13%) |
Tangible Asset Value | $483,110,000 (449.31%) | $87,948,000 (-23.61%) | $115,128,000 (-60.67%) | $292,747,000 (-3.44%) |
Market Capitalization | $1,434,363,318 (651.21%) | $190,939,826 (70.27%) | $112,142,216 (-87.31%) | $883,658,807 (-58.02%) |
Average Equity | $369,224,750 (352.32%) | $81,629,500 (-36.12%) | $127,790,000 (-55.40%) | $286,505,250 (177.56%) |
Average Assets | $397,709,500 (272.95%) | $106,638,500 (-36.52%) | $167,987,750 (-46.24%) | $312,479,750 (78.12%) |
Invested Capital Average | $201,768,000 (2321.14%) | -$9,084,000 (-112.87%) | $70,597,500 (-49.54%) | $139,903,250 (2674.59%) |
Shares | 18,637,777 (117.48%) | 8,570,010 (172.82%) | 3,141,239 (-93.00%) | 44,855,777 (17.23%) |